UK markets close in 1 hour 7 minutes
Genomic Vision Société Anonyme (0QT4.L)
LSE - LSE Delayed price. Currency in EUR
0.0281-0.0034 (-10.88%)
Genomic Vision Société Anonyme
Green Square Batiment East
80-84 rue des Meuniers
https://www.genomicvision.com
Full-time employees: 33
Mr. Aaron Bensimon Ph.D. Co-Founder, CEO, Chairman of Exec. Board & Scientific Director 378.37k N/A N/A
Mr. Pierre Schwich Chief Financial Officer N/A N/A 1953
Ms. Emilie Chataignier Member of Exec. Board N/A N/A N/A
Mr. Frederic Hammel MBA Chief Operating Officer N/A N/A N/A
Mr. Mark David Lynch Global Commercial & Marketing Director N/A N/A N/A
Ms. Claire Fleury Director of HR N/A N/A N/A
Amounts are as of 31 December 2020, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
Genomic Vision Société Anonyme, a molecular diagnostics and technology company, engages in the development of single DNA detection tools for research and in vitro diagnostics in France. The company offers FiberVision, a molecular combing platform that helps in DNA analysis workflow; FiberComb, a molecular combing system, which stretches single DNA molecules onto a vinyl silane glass surface; FiberVision, a scanner that acquires high resolution images of the whole surface of the coverslip with a hands-off workflow; FiberStudio, a software, which detects hybridization signals and analyzes data to generate results and reporting; FiberPrep, a DNA extraction kit that delivers purified DNA solutions for molecular combing; and accessories, such as custom treated glass carriers and disposable DNA reservoirs for use with the MCS, as well as sample cartridges for scanners. It also provides FiberProbes for BRCA that is a set of Genomic Morse Codes for the detection of mutations occurring in hereditary breast and ovarian cancer; and hereditary nonpolyposis colorectal cancer Genomic Morse Code sets, which allows the identification and characterization of various structural variations, including anomalies occurring in flanking regions of the MMR genes. In addition, the company offers combing services that allow customers to validate the planned gene editing events; detect incorrect events larger than 1kb, including incorrect deletions, insertions, or inversions; and quantify off-target/on-target ratios. It has a strategic alliance with Quest Diagnostics; and development agreement with La Timone Hospital; research and development agreement with the Institut Pasteur. Genomic Vision Société Anonyme was founded in 2004 and is headquartered in Bagneux, France.
Genomic Vision Société Anonyme's ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.